Man Luo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Man Luo has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Jiduo Liu
First Affiliated Hospital of Guangzhou University of Chinese Medicine
1 shared publication Jing He
Department of Hematology, The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, People’s Republic of China
1 shared publication- Jirui Zhong
The First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou 510405, China
1 shared publication - Xikun Liu
The First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou 510405, China
1 shared publication - Xuekui Gu
The First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou 510405, China
1 shared publication - Yaohe Li
Department of Hematology, The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, People’s Republic of China
1 shared publication
Latest Publications
- 15 November 2025
- Published by Springer Nature in International Journal of Hematology
- Vol. 123 (1) , 127-134
Chronic myeloid leukemia with atypical transcript e8a2: a case report and literature review
Chronic myeloid leukemia (CML) is characterized by the BCR::ABL1 fusion gene, resulting from Philadelphia (Ph) chromosome rearrangements that generate abnormal t (9; 22)(q34;q11) translocations. The most common fusion variants are e13a2 and e14a2. We diagnosed a case of CML with the rare e8a2 fusion variant using real-time quantitative PCR and sequencing. Although the e8a2 variant is increasingly reported in CML, comprehensive retrospective analyses remain scarce. Through a systematic review of published e8a2 BCR::ABL1 cases, we summarized the classification, treatment outcomes, and prognostic characteristics associated with this rare genotype. This analysis aims to provide additional evidence to facilitate improved diagnosis and therapeutic strategies for e8a2-positive CML patients.
- 15 November 2025
- Published by Springer Nature in International Journal of Hematology
- Vol. 123 (1) , 127-134
Chronic myeloid leukemia with atypical transcript e8a2: a case report and literature review
Chronic myeloid leukemia (CML) is characterized by the BCR::ABL1 fusion gene, resulting from Philadelphia (Ph) chromosome rearrangements that generate abnormal t (9; 22)(q34;q11) translocations. The most common fusion variants are e13a2 and e14a2. We diagnosed a case of CML with the rare e8a2 fusion variant using real-time quantitative PCR and sequencing. Although the e8a2 variant is increasingly reported in CML, comprehensive retrospective analyses remain scarce. Through a systematic review of published e8a2 BCR::ABL1 cases, we summarized the classification, treatment outcomes, and prognostic characteristics associated with this rare genotype. This analysis aims to provide additional evidence to facilitate improved diagnosis and therapeutic strategies for e8a2-positive CML patients.